Clinical Trials Logo

Arthritis clinical trials

View clinical trials related to Arthritis.

Filter by:

NCT ID: NCT05359107 Not yet recruiting - Sarcopenia Clinical Trials

The "Free From Pain Exercise Book" Versus "The Back Book".

Start date: January 1, 2023
Phase: N/A
Study type: Interventional

This pragmatic randomised control feasibility trial aims to investigate the effectiveness of the "Free From Pain Exercise Book" in comparison to "The Back Book" for reducing back pain in adults aged 60 and over. The "Free From Pain Exercise Book" contains a 12-week exercise and education programme. The programme is designed to reduce early osteoarthritic and generalised musculoskeletal pain and fear of falling in people over the age of 60. The study will compare the effects of the Free from Pain programme when engaged in independently versus the provision of "The Back Book", which is a booklet that promotes physical activity and a reduction of sedentary behaviour for the purpose of reducing back pain.

NCT ID: NCT05351060 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Novel Splinting Technique Using 3D Models

Start date: May 16, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the feasibility of a non-contact custom splint fabrication method for patients with chronic diseases suffering from hypersensitive skin or compromised skin integrity. Custom splinting by occupational therapists involves molding low-temperature thermoplastic material directly on patients' skin; however, skin sensitivity is a contraindication for splint fabrication. The study aims to recruit 10 male or female patients with either a diagnosis of scleroderma (SSc) or arthritis. A scan of the patient's hand and a 3D printer will be used to create a precise model of a patient's hand on which a custom splint will be fabricated. By taking this approach, traditional splinting is substituted by avoiding direct contact with the material on the surface of the patient's upper extremity. This technique creates therapeutic opportunities for underserved patients by expanding splinting options for patients with scleroderma and arthritis, and addressing the challenges associated with managing chronic diseases.

NCT ID: NCT05314387 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem

Start date: April 2022
Phase:
Study type: Observational

Post-market, prospective, non randomized, open label, multicentre, clinical study analysing outcomes of shoulder arthroplasty with SMR TT Hybrid Glenoid with or without SMR Cementless Finned Short Stem

NCT ID: NCT05302232 Not yet recruiting - Clinical trials for Inflammatory Arthritis

Intra-articular Injection of Lidocaine in Inflammatory Arthritis

Start date: April 18, 2022
Phase: N/A
Study type: Interventional

To assess the contributions of peripheral neurons to joint pain, the investigators plan to ask patients to rate the pain in their chosen joint before and after an injection of local anaesthetic (lidocaine) and steroid into their joint. Lidocaine blocks voltage gated sodium channels (VGSCs) leading to a reversible block of action potential propagation in peripheral nerves. If the pain intensity reduces significantly following lidocaine injection, it suggests that the patients' pain is due to peripheral sensitization, and that this is dampened by the local anaesthetic. If the pain intensity does not change or only falls slightly, then other centrally mediated factors are contributing to pain. Before the investigators can use this method, the investigators need to ensure that reductions in pain score following joint injection are not due to placebo effect. Therefore, as part of this validation study patients will be randomised to receive either lidocaine plus steroid or, as a control, just steroid injection. The steroid is the main part of therapy as it relieves inflammation over a prolonged period, but is slower acting than lidocaine, and should not have an effect within ten minutes. Any improvement in ranking of pain within 10 minutes by patients receiving just steroid will therefore be due to placebo effect. The investigators hypothesis is that there will be a significant difference in change in pain score before and after injection between the study group (lidocaine plus steroid) and control group (0.9% saline plus steroid). This will confirm the absence of a significant placebo effect and mean the differences in change in pain scores seen in the study group are due to differences in pain processing

NCT ID: NCT05291416 Not yet recruiting - Sarcopenia Clinical Trials

Sarcopenia in Children

Start date: April 1, 2022
Phase:
Study type: Observational

Juvenile idiopathic arthritis (AJI), is a frequent inflammatory disease in children, characterized by pain, arthritis, and deformities. Chronic inflammation leads to physical inactivity and can be associated with muscle weakness around affected joints, low bone strength, and mass(3). To our knowledge, no study has focused on the prevalence of sarcopenia in JIA and the data on the muscle disorder are lacking. The purpose of the present study is to detect sarcopenia and identify associated factors in children with JIA

NCT ID: NCT05290818 Not yet recruiting - Clinical trials for Osteo Arthritis Knee

Total Versus Robotic Assisted Unicompartmental Knee Replacement

TRAKER
Start date: September 2022
Phase: N/A
Study type: Interventional

The purpose of this research is to compare the functional outcomes of patients with end stage medial compartment OA of the knee undergoing a conventional mTKA to those undergoing rUKA and to assess the associated cost economics of such technology.

NCT ID: NCT05267431 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Outcomes of Biological Therapy on Rheumatoid Arthritis

Start date: June 2022
Phase:
Study type: Observational

Evaluate effect of biological therapy on activity of RA compared to usual DMARDs

NCT ID: NCT05245448 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Tetrandrine in the Treatment of Rheumatoid Arthritis

Start date: February 22, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy and safety of tetrandrine, compared with placebo in 12 week or 24 week in RA patients with inadequate response to methotrexate.

NCT ID: NCT05240859 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Real World Study of a Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis

Start date: February 22, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this multicenter, prospective, Observational study is to assess the Efficacy and Safety of an Adalimumab Biosimilar (Geleli) in Rheumatoid Arthritis in the real world setting.

NCT ID: NCT05240326 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

The Effects of Pilates Training on Exercise Capacity and Respiratory Muscle Performance in Patients With Rheumatoid Arthritis

Start date: March 15, 2022
Phase: N/A
Study type: Interventional

Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with significant functional impairment and increased risk for cardiovascular and pulmonary disease. Along with pharmacological therapy, exercise seems to be a very promising intervention to improve disease-related outcomes, including functional capacity and systemic manifestations. Despite the fact that aerobic and strengthening exercises have been shown to be useful in patients with RA, there have been limited research on the effects of pilates training. Therefore, we aimed to investigate the effect of clinical pilates training on exercise capacity, respiratory and peripheral muscle strength, respiratory muscle endurance, respiratory function, pain, balance, core stability, dyspnea, functional status, fatigue, quality of life, depression and anxiety in patients with RA.